N. Alagel

Efficacy and tolerability of cetuximab 750 mg/m2 every three weeks in metastatic colorectal cancer

BackgroundEarlier studies that established weekly dosing of cetuximab did not reach a maximum-tolerated dose. Subsequent pharmacokinetic studies showed equal efficacy and toxicity for the...

K. Alshammari ;

N. Alagel ;

H. Elhariry ;

M. Aseafan ;

B. Alshamsan ;

S. Bazarbashi ;

06/25/2023

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

N. Alagel

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products